Treatment for myasthenia gravis using B-cell antibodies

Shingo Konno

Presentation information

Symposium

[S-21] Symposium 21 Novel molecular target drugs for MG: How should we use them?

Thu. May 20, 2021 4:15 PM - 6:15 PM Room 07 (ICC Kyoto 1F Room D)

Chair：Murai Hiroyuki(International University of Health and Welfare),Suzuki Shigeaki(Department of Neurology, Keio University School of Medicine)

[S-21-3] Treatment for myasthenia gravis using B-cell antibodies

^○Shingo Konno (Department of Neurology, Toho University Faculty of Medicine, Japan)

Education
Toho University Faculty of Medicine School of Medicine, 1994-2001, MD
Toho University Graduate School of Medicine, 2003-2007, PhD

Current Post
Assistant Professor, Department of Neurology, Toho University Faculty of Medicine, 2016-present

Past Post
Visiting Researcher, Sidney Kimmel Medical College of Thomas Jefferson University, 2015-2016
Assistant, Department of Neurology, Toho University Faculty of Medicine, 2007-2014

Abstract password authentication.
Password is written on a pocket program and name badge.